Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Arkansas becomes first U.S. state to ban treatments for transgender youth

Published 04/06/2021, 03:41 PM
Updated 04/06/2021, 07:05 PM
© Reuters. FILE PHOTO: Arkansas' governor, Hutchinson, pictured speaking in 2016

By Daniel Trotta

(Reuters) - Arkansas on Tuesday became the first U.S. state to ban certain types of treatment to transgender youth, overriding a veto by Governor Asa Hutchinson and inviting lawsuits from civil rights groups that have vowed to stop it.

The law threatens any healthcare professional who provides puberty blockers, cross-sex hormones or gender-affirming surgery to minors with losing their medical license and opens them up to lawsuits from patients who later regret their procedures.

At least 16 other states are considering similar legislation, which transgender advocates have attacked, saying that cutting off badly needed care to adolescents would inevitably lead to more suicides.

The healthcare bills are among dozens of others introduced across the country that would limit transgender rights in what critics have called unconstitutional attempts to animate the right wing in the U.S. culture war.

But proponents of the bills, nearly all Republican, say they want to protect kids from medical procedures they will later regret.

They also accuse transgender advocates of minimizing the side effects of puberty blockers and cross-sex hormones, and point to the small number of cases where transgender people reverse their decision to transition.

Hutchinson, a Republican in his second and final term, had vetoed the legislation on Monday, calling it "a vast government overreach."

But the Arkansas House voted 71 to 24 on Tuesday to override the veto, followed shortly thereafter by the Senate, 25 to eight. The bill will become law 90 days after the end of the legislative session, which is currently scheduled to end on April 30.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The American Academy of Pediatrics, which represents 67,000 pediatricians, was among the medical organizations to oppose the bill, saying it would cut off trans kids from needed medical care and needlessly increase their already high risk of suicide.

"Today Arkansas legislators disregarded widespread, overwhelming, and bipartisan opposition to this bill and continued their discriminatory crusade against trans youth," said Holly Dickson, director of the Arkansas chapter of the American Civil Liberties Union, which has vowed to challenge the law in court.

Experts say each step in a transgender child or adolescent's treatment is undertaken with the consultation of doctors, therapists and social workers, often over months if not years.

Those who consistently identify as transgender can be prescribed puberty blockers. Others graduate to cross-sex hormone therapy, a more serious commitment to transitioning. A small number opt for some type of surgery with parental consent, but experts say those cases for minors are extremely rare.

"There's tons of solid science supporting this approach. There's a general consensus among professionals in this field and in professionals in health and mental health fields in general," said Madeline Deutsch, medical director for transgender care at University of California, San Francisco.

But a minority of dissenters such as the American College of Pediatricians, representing 600 healthcare professionals, contend that with time and counseling transgender people will revert to their sex assigned at birth.

"We are basically being blackmailed (into providing hormone treatments) by that adolescent who's emotionally troubled into doing something that they don't understand," said Quentin Van Meter, president of the group. "A 13-year-old cannot wrap their head around the concept of building a biological family in their later years."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.